286 related articles for article (PubMed ID: 36606428)
1. Progress of small molecules for targeted protein degradation: PROTACs and other technologies.
Zhao HY; Xin M; Zhang SQ
Drug Dev Res; 2023 Apr; 84(2):337-394. PubMed ID: 36606428
[TBL] [Abstract][Full Text] [Related]
2. Proteomic approaches advancing targeted protein degradation.
Sathe G; Sapkota GP
Trends Pharmacol Sci; 2023 Nov; 44(11):786-801. PubMed ID: 37778939
[TBL] [Abstract][Full Text] [Related]
3. Advancement of targeted protein degradation strategies as therapeutics for undruggable disease targets.
Kannan MP; Sreeraman S; Somala CS; Kushwah RB; Mani SK; Sundaram V; Thirunavukarasou A
Future Med Chem; 2023 May; 15(10):867-883. PubMed ID: 37254917
[TBL] [Abstract][Full Text] [Related]
4. Targeted protein degrader development for cancer: advances, challenges, and opportunities.
Fang Y; Wang S; Han S; Zhao Y; Yu C; Liu H; Li N
Trends Pharmacol Sci; 2023 May; 44(5):303-317. PubMed ID: 37059054
[TBL] [Abstract][Full Text] [Related]
5. Novel strategies and promising opportunities for targeted protein degradation: An innovative therapeutic approach to overcome cancer resistance.
Zhu H; Wang J; Zhang Q; Pan X; Zhang J
Pharmacol Ther; 2023 Apr; 244():108371. PubMed ID: 36871783
[TBL] [Abstract][Full Text] [Related]
6. Progress and Challenges in Targeted Protein Degradation for Neurodegenerative Disease Therapy.
Fang Y; Wang J; Zhao M; Zheng Q; Ren C; Wang Y; Zhang J
J Med Chem; 2022 Sep; 65(17):11454-11477. PubMed ID: 36006861
[TBL] [Abstract][Full Text] [Related]
7. Drug delivery challenges and formulation aspects of proteolysis targeting chimera (PROTACs).
Saraswat AL; Vartak R; Hegazy R; Patel A; Patel K
Drug Discov Today; 2023 Jan; 28(1):103387. PubMed ID: 36184017
[TBL] [Abstract][Full Text] [Related]
8. Novel approaches to targeted protein degradation technologies in drug discovery.
Xue Y; Bolinger AA; Zhou J
Expert Opin Drug Discov; 2023 Apr; 18(4):467-483. PubMed ID: 36895136
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the development of EGFR degraders: PROTACs and LYTACs.
Hong D; Zhou B; Zhang B; Ren H; Zhu L; Zheng G; Ge M; Ge J
Eur J Med Chem; 2022 Sep; 239():114533. PubMed ID: 35728507
[TBL] [Abstract][Full Text] [Related]
10. Degradation of extracellular and membrane proteins in targeted therapy: Status quo and quo vadis.
Li Z; Ma S; Zhang S; Ma Z; Du L; Li M
Drug Discov Today; 2023 Sep; 28(9):103716. PubMed ID: 37467880
[TBL] [Abstract][Full Text] [Related]
11. Beyond canonical PROTAC: biological targeted protein degradation (bioTPD).
Wang H; Zhou R; Xu F; Yang K; Zheng L; Zhao P; Shi G; Dai L; Xu C; Yu L; Li Z; Wang J; Wang J
Biomater Res; 2023 Jul; 27(1):72. PubMed ID: 37480049
[TBL] [Abstract][Full Text] [Related]
12. PROTACs: Emerging Targeted Protein Degradation Approaches for Advanced Druggable Strategies.
Sincere NI; Anand K; Ashique S; Yang J; You C
Molecules; 2023 May; 28(10):. PubMed ID: 37241755
[TBL] [Abstract][Full Text] [Related]
13. PROTACs: Current Trends in Protein Degradation by Proteolysis-Targeting Chimeras.
Madan J; Ahuja VK; Dua K; Samajdar S; Ramchandra M; Giri S
BioDrugs; 2022 Sep; 36(5):609-623. PubMed ID: 36098871
[TBL] [Abstract][Full Text] [Related]
14. Advancing targeted protein degradation for metabolic diseases therapy.
Zhou QQ; Xiao HT; Yang F; Wang YD; Li P; Zheng ZG
Pharmacol Res; 2023 Feb; 188():106627. PubMed ID: 36566001
[TBL] [Abstract][Full Text] [Related]
15. Unlocking the potential of PROTACs: A comprehensive review of protein degradation strategies in disease therapy.
Bhole RP; Kute PR; Chikhale RV; Bonde CG; Pant A; Gurav SS
Bioorg Chem; 2023 Oct; 139():106720. PubMed ID: 37480814
[TBL] [Abstract][Full Text] [Related]
16. Targeting androgen receptor degradation with PROTACs from bench to bedside.
Jia X; Han X
Biomed Pharmacother; 2023 Feb; 158():114112. PubMed ID: 36508999
[TBL] [Abstract][Full Text] [Related]
17. Redefining the Scope of Targeted Protein Degradation: Translational Opportunities in Hijacking the Autophagy-Lysosome Pathway.
Cassidy K; Zhao H
Biochemistry; 2023 Feb; 62(3):580-587. PubMed ID: 34569233
[TBL] [Abstract][Full Text] [Related]
18. Natural Product-Inspired Targeted Protein Degraders: Advances and Perspectives.
Li J; Cai Z; Li XW; Zhuang C
J Med Chem; 2022 Oct; 65(20):13533-13560. PubMed ID: 36205223
[TBL] [Abstract][Full Text] [Related]
19. Target and tissue selectivity of PROTAC degraders.
Guenette RG; Yang SW; Min J; Pei B; Potts PR
Chem Soc Rev; 2022 Jul; 51(14):5740-5756. PubMed ID: 35587208
[TBL] [Abstract][Full Text] [Related]
20. Targeted protein degradation in drug development: Recent advances and future challenges.
Song J; Hu M; Zhou J; Xie S; Li T; Li Y
Eur J Med Chem; 2023 Dec; 261():115839. PubMed ID: 37778240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
